全文获取类型
收费全文 | 29422篇 |
免费 | 3476篇 |
国内免费 | 636篇 |
专业分类
耳鼻咽喉 | 525篇 |
儿科学 | 413篇 |
妇产科学 | 401篇 |
基础医学 | 1150篇 |
口腔科学 | 350篇 |
临床医学 | 2086篇 |
内科学 | 1659篇 |
皮肤病学 | 171篇 |
神经病学 | 495篇 |
特种医学 | 981篇 |
外国民族医学 | 48篇 |
外科学 | 6019篇 |
综合类 | 3751篇 |
预防医学 | 1275篇 |
眼科学 | 277篇 |
药学 | 1754篇 |
16篇 | |
中国医学 | 717篇 |
肿瘤学 | 11446篇 |
出版年
2024年 | 90篇 |
2023年 | 539篇 |
2022年 | 997篇 |
2021年 | 1390篇 |
2020年 | 1374篇 |
2019年 | 1216篇 |
2018年 | 1140篇 |
2017年 | 1155篇 |
2016年 | 1279篇 |
2015年 | 1262篇 |
2014年 | 2224篇 |
2013年 | 2174篇 |
2012年 | 1877篇 |
2011年 | 2008篇 |
2010年 | 1717篇 |
2009年 | 1600篇 |
2008年 | 1457篇 |
2007年 | 1563篇 |
2006年 | 1365篇 |
2005年 | 1151篇 |
2004年 | 928篇 |
2003年 | 801篇 |
2002年 | 693篇 |
2001年 | 586篇 |
2000年 | 463篇 |
1999年 | 400篇 |
1998年 | 321篇 |
1997年 | 256篇 |
1996年 | 199篇 |
1995年 | 170篇 |
1994年 | 132篇 |
1993年 | 82篇 |
1992年 | 100篇 |
1991年 | 77篇 |
1990年 | 61篇 |
1989年 | 63篇 |
1988年 | 74篇 |
1987年 | 57篇 |
1986年 | 48篇 |
1985年 | 91篇 |
1984年 | 57篇 |
1983年 | 51篇 |
1982年 | 54篇 |
1981年 | 45篇 |
1980年 | 46篇 |
1979年 | 30篇 |
1978年 | 22篇 |
1977年 | 22篇 |
1976年 | 13篇 |
1975年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2020,32(5):303-315
The lung is the preferred site of metastasis from soft tissue sarcoma (STS). This systematic review aims to evaluate the outcomes of stereotactic body radiotherapy (SBRT) and metastasectomy (MTS) for the treatment of lung metastases from STS. A systematic review was carried out according to the PRISMA protocol. PubMed, Medline, EMBASE, Cochrane Library, Ovid and Web of Knowledge databases were searched for English-language articles to December 2018 using a predefined strategy. Retrieved studies were independently screened and rated for relevance. Data were extracted by two researchers. In total, there were 1306 patients with STS: 1104 underwent MTS and 202 had SBRT. The mean age ranged from 40 to 55.8 years in the MTS group and from 47.9 to 64 years in the SBRT group. The cumulative death rate was 72% (95% confidence interval 59–85%) in the MTS group and 56% (38–74%) in the SBRT group. The cumulative mean overall survival time was 46.7 months (36.4–57.0%) in the MTS group and 47.6 months (33.7–61.5%) in the SBRT group. The cumulative rate of patients alive with disease was 5% (2–9%) in the MTS group and 15% (6–36%) in the SBRT group. Finally, the cumulative rate of patients alive without disease in the two groups was 19% (9–29%) and 20% (10–50%), respectively. Our study showed that local treatment of pulmonary metastases from STS with SBRT, compared with surgery, was associated with a lower cumulative overall death rate and similar overall survival time and survival rates without disease. By contrast, SBRT was associated with a higher survival rate with disease than MTS. Large randomised trials are necessary to confirm these findings and to establish whether SBRT may be a reliable option for early stage disease. 相似文献
32.
室管膜瘤是一种原发于神经上皮的中枢神经系统肿瘤,病变累及脑和脊髓,多发于儿童。基因分型的新分类方法,为室管膜瘤的治疗和预后评估提供了更为可靠的依据。室管膜瘤对辅助治疗的敏感性低是造成患儿预后较差的重要原因之一。该文对近年来儿童室管膜瘤的分型、诊断、治疗策略等进行综述。 相似文献
33.
《中国现代医生》2020,58(34):112-115
目的 探讨地佐辛术后镇痛对高龄患者围术期肝功能的影响。方法 选择2018 年1 月~2020 年6 月吉安市中心人民医院麻醉科收治的ASA 分级Ⅱ~Ⅲ级高龄患者80 例,按照随机数字表法,分为A 组、B 组、C 组、D 组,每组各20 例。分别给予0.4 mg/kg、0.5 mg/kg、0.6 mg/kg、0.7 mg/kg 地佐辛进行术后镇痛,评估术后1、2、6、12、24、48 h 患者的疼痛程度[视觉模拟评分法(VAS)]、术后镇静效果(Ramsay 评分法)及肝功能指标(ALT、AST)水平,评价不同剂量的地佐辛术后镇痛对高龄患者围术期肝功能的影响。结果 C 组术后患者不同时间段VAS 疼痛评分低于A 组、B 组、D 组,差异有统计学意义(P<0.05);四组患者术后1、2、6 h Ramsay 镇静评分比较,差异有统计学意义(P<0.05);但术后12、24、48 h Ramay 镇痛评分比较,差异无统计学意义(P>0.05)。C 组肝功能指标ALT、AST优于A 组、B 组、D 组,差异有统计学意义(P<0.05)。结论 高龄患者术后镇痛应用0.6 mg/kg地佐辛对围术期肝功能的影响最小。 相似文献
34.
35.
36.
《Obstetrics, Gynaecology and Reproductive Medicine》2020,30(10):303-308
Cancer is rarely diagnosed during pregnancy, but the incidence of cases is increasing. Diagnosis may be delayed due to an assumption that symptoms are pregnancy-related, or a reluctance to perform investigations. Multidisciplinary discussion is vital, with decision-making involving the obstetrician, patient and family. Many cancers can be treated during pregnancy. Surgery is considered safe and chemotherapy after the first trimester does not increase fetal risks. Timing and mode of delivery will depend on the treatment plans as well as obstetric considerations. The rate of preterm birth is increased, but overall neonatal and paediatric outcomes do not seem to be affected. 相似文献
37.
38.
39.
目的 探讨接受新辅助放化疗的局部晚期食管鳞癌患者新辅助放疗剂量与病理完全缓解(pCR)的关系。方法 收集2017-2019年间在四川大学华西医院肿瘤中心经病理确诊为食管鳞癌并接受新辅助放化疗和手术的 116例局部晚期患者临床资料。116例患者中 40~45Gy组 80例,≥45Gy组 36例,分析两组术后pCR率。结果 全组患者的pCR率为38.8%(45/116),40~45Gy组与≥45Gy组的pCR率分别为44%(35/80)和28%(10/36)(P=0.105)。结论 术前新辅助采用较高的放疗剂量不增加局部晚期食管鳞癌的pCR率,有必要进行前瞻性的临床研究确定合适的新辅助放疗剂量。 相似文献
40.
A. Prado Rodríguez R. Mato Búa L. Mera Mujico J. Arca Suárez M. López Sánchez L. Sampayo Rodríguez P. Rama-Maceiras 《Revista espa?ola de anestesiología y reanimación》2021,68(6):361-366
Serum lactate is a non-specific marker of tissue hypoperfusion. Elevated serum lactate is used in the differential diagnosis of acute intestinal ischemia. Although this practice is controversial, in the absence of other validated markers lactate is still used because of its high sensitivity.We present the cases of two patients who developed acute mesenteric ischemia as a post-surgical complication. The patients reported moderate abdominal pain —a non-specific symptom in the postoperative context— and tests showed progressively increasing serum lactate levels, which facilitated suspicion and subsequent diagnostic confirmation through an imaging test.These cases highlight the physiopathological importance of lactate elevation in the perioperative context and of performing a differential diagnosis of its possible causes, including mesenteric ischemia. Although the outcome was negative in the first case, early suspicion allowed us to make an effective diagnosis and administer appropriate treatment in the second patient. 相似文献